Search

Author/Creator Stephan, C

13. PEPDar: A randomized prospective noninferiority study of ritonavir‐boosted darunavir for HIV post‐exposure prophylaxis. Issue 6 (11th May 2016)

Authors:
Fätkenheuer, G; Jessen, H; Stoehr, A; Jung, N; Jessen, AB; Kümmerle, T; Berger, M; Bogner, JR; Spinner, CD; Stephan, C; Degen, O; Vogelmann, R; Spornraft‐Ragaller, P; Schnaitmann, E; Jensen, B; Ulmer, A; Kittner, JM; Härter, G; Malfertheiner, P; Rockstroh, J
Journal:
HIV medicine
Issue:
Volume 17:Issue 6(2016:Jul.)
Page Start:
453
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Similar long‐term efficacy of dual therapy containing raltegravir and a boosted protease inhibitor versus standard triple therapies in pretreated HIV‐1‐infected patients in a retrospective, real‐life cohort of 14 years. Issue 9 (3rd July 2018)

Authors:
Krznaric, I; Bickel, M; Carganico, A; De Leuw, P; Haberl, A; Knecht, G; Koegl, C; Lauscher, P; Schüttfort, G; Stephan, C; Wolf, E; Wolf, T
Journal:
HIV medicine
Issue:
Volume 19:Issue 9(2018)
Page Start:
662
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

16. Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment. Issue 9 (26th June 2020)

Authors:
Mocroft, A; Neesgard, B; Zangerle, R; Rieger, A; Castagna, A; Spagnuolo, V; Antinori, A; Lampe, FC; Youle, M; Vehreschild, JJ; Mussini, C; Borghi, V; Begovac, J; Duvivier, C; Gunthard, HF; Rauch, A; Tiraboschi, J; Chkhartishvili, N; Bolokadze, N; Wit, F
Journal:
HIV medicine
Issue:
Volume 21:Issue 9(2020)
Page Start:
599
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗